Literature DB >> 28093527

Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia.

Kaivon Assani1, Chandra L Shrestha1, Frank Robledo-Avila1, Murugesan V Rajaram2, Santiago Partida-Sanchez1, Larry S Schlesinger2, Benjamin T Kopp3,2,4.   

Abstract

Macrophage intracellular pathogen killing is defective in cystic fibrosis (CF), despite abundant production of reactive oxygen species (ROS) in lung tissue. Burkholderia species can cause serious infection in CF and themselves affect key oxidase components in murine non-CF cells. However, it is unknown whether human CF macrophages have an independent defect in the oxidative burst and whether Burkholderia contributes to this defect in terms of assembly of the NADPH oxidase complex and subsequent ROS production. In this article, we analyze CF and non-CF human monocyte-derived macrophages (MDMs) for ROS production, NADPH assembly capacity, protein kinase C expression, and calcium release in response to PMA and CF pathogens. CF MDMs demonstrate a nearly 60% reduction in superoxide production after PMA stimulation compared with non-CF MDMs. Although CF MDMs generally have increased total NADPH component protein expression, they demonstrate decreased expression of the calcium-dependent protein kinase C conventional subclass α/β leading to reduced phosphorylation of NADPH oxidase components p47 phox and p40 phox in comparison with non-CF MDMs. Ingestion of B. cenocepacia independently contributes to and worsens the overall oxidative burst deficits in CF MDMs compared with non-CF MDMs. Together, these results provide evidence for inherent deficits in the CF macrophage oxidative burst caused by decreased phosphorylation of NADPH oxidase cytosolic components that are augmented by Burkholderia These findings implicate a critical role for defective macrophage oxidative responses in persistent bacterial infections in CF and create new opportunities for boosting the macrophage immune response to limit infection.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28093527      PMCID: PMC5322234          DOI: 10.4049/jimmunol.1502609

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Isolation of Burkholderia cenocepacia J 2315 from non-cystic fibrosis pediatric patients in India.

Authors:  Meenakshi G Satpute; Nilima V Telang; Prashant K Dhakephalkar; Krishna B Niphadkar; Suresh G Joshi
Journal:  Am J Infect Control       Date:  2011-05       Impact factor: 2.918

Review 2.  Host-pathogen interplay in the respiratory environment of cystic fibrosis.

Authors:  Lael M Yonker; Cristina Cigana; Bryan P Hurley; Alessandra Bragonzi
Journal:  J Cyst Fibros       Date:  2015-03-19       Impact factor: 5.482

3.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

4.  Arabinosylated lipoarabinomannan (Ara-LAM) mediated intracellular mechanisms against tuberculosis infection: involvement of protein kinase C (PKC) mediated signaling.

Authors:  Shibali Das; Oindrila Bhattacharjee; Avranil Goswami; Nishith K Pal; Subrata Majumdar
Journal:  Tuberculosis (Edinb)       Date:  2014-12-11       Impact factor: 3.131

5.  Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Sheetal Kotrange; Dalia H A Abdelaziz; Christie Newland; Roberto Rosales-Reyes; Benjamin Kopp; Karen McCoy; Richard Montione; Larry S Schlesinger; Mikhail A Gavrilin; Mark D Wewers; Miguel A Valvano; Amal O Amer
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

6.  Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

Authors:  A M Jones; M E Dodd; J R W Govan; V Barcus; C J Doherty; J Morris; A K Webb
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

7.  Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis.

Authors:  S Brennan; P D Sly; C L Gangell; N Sturges; K Winfield; M Wikstrom; S Gard; J W Upham
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

8.  Defective protein kinase C-mediated actions in cystic fibrosis neutrophils.

Authors:  I Graff; A Schram-Doumont; C Szpirer
Journal:  Cell Signal       Date:  1991       Impact factor: 4.315

9.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

Authors:  L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

10.  Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia.

Authors:  Karen E Keith; Daniel W Hynes; Judith E Sholdice; Miguel A Valvano
Journal:  Microbiology       Date:  2009-04       Impact factor: 2.777

View more
  16 in total

1.  The 24th Annual Midwest Microbial Pathogenesis Meeting.

Authors:  Patricia A Champion; Joshua D Shrout
Journal:  J Bacteriol       Date:  2018-02-26       Impact factor: 3.490

2.  Inhibitors of DAG metabolism suppress CCR2 signalling in human monocytes.

Authors:  Priscilla Day; Lisa Burrows; David Richards; Samuel J Fountain
Journal:  Br J Pharmacol       Date:  2019-06-17       Impact factor: 8.739

3.  Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

Authors:  Frank H Robledo-Avila; Juan de Dios Ruiz-Rosado; Kenneth L Brockman; Benjamin T Kopp; Amal O Amer; Karen McCoy; Lauren O Bakaletz; Santiago Partida-Sanchez
Journal:  J Immunol       Date:  2018-08-17       Impact factor: 5.422

4.  Enhancing Cystic Fibrosis Immune Regulation.

Authors:  Anna M van Heeckeren; Morgan T Sutton; David R Fletcher; Craig A Hodges; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

5.  Genome-Wide Association Study of Cryptosporidiosis in Infants Implicates PRKCA.

Authors:  Genevieve L Wojcik; Poonum Korpe; Chelsea Marie; Alexander J Mentzer; Tommy Carstensen; Josyf Mychaleckyj; Beth D Kirkpatrick; Stephen S Rich; Patrick Concannon; A S G Faruque; Rashidul Haque; William A Petri; Priya Duggal
Journal:  mBio       Date:  2020-02-04       Impact factor: 7.867

6.  Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages.

Authors:  Chandra L Shrestha; Kaivon D Assani; Hannah Rinehardt; Florentina Albastroiu; Shuzhong Zhang; Richard Shell; Amal O Amer; Larry S Schlesinger; Benjamin T Kopp
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

Review 7.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

8.  Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages.

Authors:  Shuzhong Zhang; Chandra L Shrestha; Benjamin L Wisniewski; Hanh Pham; Xucheng Hou; Wenqing Li; Yizhou Dong; Benjamin T Kopp
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

Review 9.  Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.

Authors:  Giulio Cabrini; Alessandro Rimessi; Monica Borgatti; Ilaria Lampronti; Alessia Finotti; Paolo Pinton; Roberto Gambari
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

10.  Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.

Authors:  Shuzhong Zhang; Chandra L Shrestha; Benjamin T Kopp
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.